Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for cognitive and brain recovery after pediatric brain tumor treatment
ACTRN12622000045718Phase 3Recruiting
- Sponsor
- SickKids
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in brain neoplasm comparing Metformin with Placebo (2 arms). Primary endpoints: Declarative memory improvement, Working memory improvement and 1 more. Started Mar 2023; status: recruiting.
02
Drugs
metformin
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on ACTRN12622000045718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000045718.